Galena Biopharma  (GALE) to Present at the 2012 Gateway Conference on September 6  
8/21/2012 9:20:17 AM

SAN FRANCISCO, CA--(Marketwire - August 21, 2012) - Galena Biopharma, Inc. (NASDAQ: GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, has been invited to present at the 2012 Gateway Conference being held on September 6, 2012 at the W San Francisco Hotel.

Galena Biopharma management is scheduled to present at 10:30 a.m. Pacific time, with one-on-one meetings held throughout the day. Management will provide an overview of the company and discuss the current status of its pipeline assets.

The presentation will also be webcasted live at, under the Presenting Companies tab.

To schedule a one-on-one meeting, visit and click on the Register/Login tab. You may also email your request to or call Ron Both at (949) 574-3860.

About the Gateway Conference
The Gateway Conference is designed to provide a unique gateway between influential members of the investment community and a select group of compelling publicly-traded companies. Portfolio managers, research analysts and brokers from buy-side and sell-side institutions will have the opportunity to learn about more than 50 emerging growth companies across a broad range of industries, from technology, business services and digital media, to clean-tech, consumer/retail, life sciences and natural resources. For more information, visit

The invitation-only conference is hosted by Liolios Group, one of the nation's top investor relations agencies, and sponsored by leading firms that service the financial community. For more information about Liolios Group, visit

About Galena Biopharma
Galena Biopharma, Inc. (NASDAQ: GALE) is a Portland, Oregon-based, biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at

Company Contact
Madeline Hatton
855-855-4253, ext. 109
Email Contact

Conference Contact:
Ron Both
Liolios Group, Inc.
Tel (949) 574-3860
Email Contact